Lipids modulate the dynamics of GPCR:β-arrestin interaction - Nature
Yesterday • Google News
Structure Therapeutics Inc. American Depositary Shares (GPCR)
US$ 25.57-4.66%
Price Chart
Key Statistics
Market Cap
$ 1.29B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
587.5K
52W High
$ 62.74
52W Low
$ 13.22
Dividend Yield
0.00%
Beta
-1.79
Technicals
50-Day MA
21.8784
200-Day MA
30.095
52 Week High
62.74
52 Week Low
13.22
About GPCR
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs .
Employees
183
Headquarters
South San Francisco, CA
CEO
Dr. Raymond C. Stevens Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg